The firm has also announced the expansion of its R&D quality systems service for the preclinical (GLP) and clinical (GCP) phases in the development of active ingredients and drugs.
The company’s consultancy services portfolio expansion took place earlier this month when it purcahsed Spain-based dTC Development Team Consulting, according to Manufacturing Chemist.
Set up in 2000, dTC Development Team Consulting is specialist in executing projects, which deal with GXP regulatory compliance and with the improvement of manufacturing processes based on QbD concepts.
Telstar claims that the integration of the specialised service enables the company to position itself as a major provider of GLP services for non-clinical development, GCP services for clinical development, QbD services for process development and redesign, PAT/NIR services for process monitoring and control and GMP services for GMP production and operational excellence.